http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104042898-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6e519e50084b516cc7a44d819033d37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8968 |
| filingDate | 2014-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba2ee27a27f73b0b25bb4b23bf29633a |
| publicationDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104042898-B |
| titleOfInvention | Traditional Chinese medicine composition for treating fetomaternal blood group incompatibility and preparation method thereof |
| abstract | The invention belongs to the field of traditional Chinese medicines, relates to a traditional Chinese medicine composition and a preparation method thereof, and in particular relates to a traditional Chinese medicine composition for treating fetomaternal blood group incompatibility and a preparation method thereof. In order to overcome the existing technical problems of relatively high hepatotoxicity and poor curative effect of the current chemical medicines for treating the fetomaternal blood group incompatibility, the traditional Chinese medicine composition for treating or preventing the fetomaternal blood group incompatibility comprises the following components: 10-50 parts of epimedium, 10-20 parts of oriental wormwood, 5-20 parts of angelica sinensis, 5-15 parts of honeysuckle, 5-10 parts of the root of kudzu vine, 5-15 parts of poria cocos, 5-15 parts of lotus leaf, 1-10 parts of cassia twig, 5-15 parts of wolfberry, 9-15 parts of astragalus membranaceus, 9-15 parts of felwort, 5-15 parts of mint, 1.5-9 parts of radix ophiopogonis, 5.5-15 parts of radix paeoniae alba, 6-9 parts of spatholobus suberctu and 10-15 parts of liquorice. The traditional Chinese medicine composition has an excellent treatment effect in the aspect of treating or preventing the fetomaternal blood group incompatibility, and has low medical side effect and remarkable clinical popularization value. |
| priorityDate | 2014-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.